Potassium Supplementation and Prevention of Atrial Fibrillation After Cardiac Surgery: The TIGHT K Randomized Clinical Trial.
心臟手術後鉀補充與預防心房顫動:TIGHT K 隨機臨床試驗。
JAMA 2024-08-31
Experience of a Bespoke Hyperkalaemia Clinic to Facilitate Prescribing of Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Heart Failure with Reduced Ejection Fraction.
心力衰竭患者配戴降低射血分數的腎素-血管緊張素-醛固酮系統抑制劑處方的特設高鉀血症門診的經驗。
Cardiorenal Med 2023-03-21
Serum Potassium and Risk of Death or Kidney Replacement Therapy in Older People With CKD Stages 4-5: Eight-Year Follow-up.
腎功能衰竭4-5期老年人血清鉀和死亡或腎臟替代治療風險:八年追蹤研究。
Am J Kidney Dis 2023-08-30
Randomized Trial on the Effect of Oral Potassium Chloride Supplementation on the Thiazide-Sensitive Sodium Chloride Cotransporter in Healthy Adults.
口服氯化鉀補充對健康成人嗜噻嗪敏感性鈉氯共轉運輸蛋白的影響:隨機試驗。
Kidney Int Rep 2023-06-08
Point-of-Care Chemistry-Guided Dialysate Adjustment to Reduce Arrhythmias: A Pilot Trial.
點-of-Care 化學引導透析液調整以減少心律不整:一項試驗性研究。
Kidney Int Rep 2024-01-30
Inhibition of the K<sub>Ca</sub>2 potassium channel in atrial fibrillation: a randomized phase 2 trial.
房顫中K<sub>Ca</sub>2鉀通道的抑制:一項隨機2期試驗。
Nat Med 2024-02-10
Evaluation of the effect of empagliflozin on prevention of atrial fibrillation after coronary artery bypass grafting: a double-blind, randomized, placebo-controlled trial.
冠狀動脈旁路移植術後 empagliflozin 預防心房纖維顫動效果的評估:雙盲、隨機、安慰劑對照試驗。
Naunyn Schmiedebergs Arch Pharmacol 2024-07-02
Validation of Noninvasive Detection of Hyperkalemia by Artificial Intelligence-Enhanced Electrocardiography in High Acuity Settings.
在高危環境中,利用人工智慧增強心電圖驗證非侵入性高鉀血症檢測。
Clin J Am Soc Nephrol 2024-08-08
Inverse association between serum chloride levels and the risk of atrial fibrillation in chronic kidney disease patients.
慢性腎病患者血清氯離子水平與心房顫動風險之間的反向關聯。
Clin Kidney J 2024-08-12
Impact of Sodium-glucose Cotransporter 2 Inhibitor on Recurrence and Cardiovascular Outcomes after Catheter Ablation for Atrial Fibrillation in Patients with Heart Failure.
鈉-葡萄糖共轉運蛋白 2 抑制劑對心衰竭患者經導管消融治療心房顫動後復發及心血管結果的影響。
Heart Rhythm 2024-08-21